Affordable Access

deepdyve-link
Publisher Website

Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.

Authors
  • Park, Gun Ha1, 2
  • Lee, Chang Min1, 2
  • Song, Jae Won1, 2
  • Jung, Moon Chan1, 2
  • Kim, Jwa Kyung1, 2, 3
  • Song, Young Rim1, 2
  • Kim, Hyung Jik1, 2
  • Kim, Sung Gyun1, 2, 3
  • 1 Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. , (North Korea)
  • 2 Kidney Research Institute, Hallym University Sacred Heart Hospital, Anyang, Korea. , (North Korea)
  • 3 Department of Clinical Immunology, Hallym University Sacred Heart Hospital, Anyang, Korea. , (North Korea)
Type
Published Article
Journal
The Korean journal of internal medicine
Publication Date
May 01, 2018
Volume
33
Issue
3
Pages
561–567
Identifiers
DOI: 10.3904/kjim.2016.155
PMID: 28286940
Source
Medline
Keywords
License
Unknown

Abstract

The early response to tolvaptan treatment was better in patients with SIADH than in those with CHF. Thus, the tolvaptan treatment strategy should be differed between patients with SIADH and those with CHF.

Report this publication

Statistics

Seen <100 times